Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy.

AIDS (London, England) - 27 Jul 2001

Birk M, Svedhem V, Sönnerborg A

Abstract excerpt

OBJECTIVE: To study the kinetics of HIV-1 RNA and drug-induced mutations after cessation of antiretroviral therapy (ART). DESIGN AND METHODS: Successive plasma samples from 26 patients were tested for HIV-1 RNA by PCR and for mutations associated with drug resistance by sequencing of the pol gene. RESULTS: After cessation of ART the phase of undetectable virus (< 50 copies/ml), ranging from 6 to more than 29...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Microbial
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, pol

Share to HIV Infections

Share to Sequence Analysis, RNA

Share to Viral Load

Source

Identifiers

PMID: 11504957
DOI: 10.1097/00002030-200107270-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy.PMID 11504957Read ↗

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapySemantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.Semantic proximity Read ↗

Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.Semantic proximity Read ↗

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.Semantic proximity Read ↗

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.Semantic proximity Read ↗

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.Semantic proximity Read ↗

Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.Semantic proximity Read ↗

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.Semantic proximity Read ↗

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.Semantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.